Aurobindo Pharma Statistics

Total Valuation

NSE:AUROPHARMA has a market cap or net worth of INR 633.45 billion. The enterprise value is 649.11 billion.

Market Cap	633.45B
Enterprise Value	649.11B

Important Dates

The next estimated earnings date is Wednesday, May 28, 2025.

Earnings Date	May 28, 2025
Ex-Dividend Date	n/a

Share Statistics

NSE:AUROPHARMA has 580.80 million shares outstanding. The number of shares has decreased by -0.48% in one year.

Current Share Class	n/a
Shares Outstanding	580.80M
Shares Change (YoY)	-0.48%
Shares Change (QoQ)	-0.50%
Owned by Insiders (%)	15.31%
Owned by Institutions (%)	33.86%
Float	272.89M

Valuation Ratios

The trailing PE ratio is 18.23 and the forward PE ratio is 14.38. NSE:AUROPHARMA's PEG ratio is 1.23.

PE Ratio	18.23
Forward PE	14.38
PS Ratio	2.06
PB Ratio	2.06
P/TBV Ratio	2.36
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	1.23

Financial Ratio History

Enterprise Valuation

EV / Earnings	18.59
EV / Sales	2.10
EV / EBITDA	9.80
EV / EBIT	12.98
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.27
Debt / EBITDA	1.27
Debt / FCF	n/a
Interest Coverage	12.22

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	8.45%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	11.89M
Profits Per Employee	1.34M
Employee Count	26,015
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +3.00% in the last 52 weeks. The beta is 0.66, so NSE:AUROPHARMA's price volatility has been lower than the market average.

Beta (5Y)	0.66
52-Week Price Change	+3.00%
50-Day Moving Average	1,169.36
200-Day Moving Average	1,319.60
Relative Strength Index (RSI)	42.81
Average Volume (20 Days)	976,005

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:AUROPHARMA had revenue of INR 309.22 billion and earned 34.91 billion in profits. Earnings per share was 59.81.

Revenue	309.22B
Gross Profit	178.80B
Operating Income	50.11B
Pretax Income	49.61B
Net Income	34.91B
EBITDA	65.72B
EBIT	50.11B
Earnings Per Share (EPS)	59.81

Full Income Statement

Balance Sheet

The company has 68.68 billion in cash and 84.27 billion in debt, giving a net cash position of -15.59 billion or -26.84 per share.

Cash & Cash Equivalents	68.68B
Total Debt	84.27B
Net Cash	-15.59B
Net Cash Per Share	-26.84
Equity (Book Value)	308.85B
Book Value Per Share	528.88
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 57.82%, with operating and profit margins of 16.21% and 11.29%.

Gross Margin	57.82%
Operating Margin	16.21%
Pretax Margin	16.04%
Profit Margin	11.29%
EBITDA Margin	21.25%
EBIT Margin	16.21%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 3.00, which amounts to a dividend yield of 0.28%.

Dividend Per Share	3.00
Dividend Yield	0.28%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.48%
Shareholder Yield	0.75%
Earnings Yield	5.51%
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on July 20, 2015. It was a forward split with a ratio of 2.

Last Split Date	Jul 20, 2015
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a